Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (111-120 of 273) with videos related to

Pageof 28
Sort By:
Science (New York, N.Y.)|July 18, 1986
Studies of the human c-myb gene and its product in human acute leukemiasD J Slamon, T C Boone, D C Murdock, et al.
Clinical Breast Cancer|September 3, 2005
Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumabRobert D Mass, Michael F Press, Steven Anderson, et al.
The Journal of Pathology|June 30, 2015
Many private mutations originate from the first few divisions of a human colorectal adenomaHaeyoun Kang, Matthew P Salomon, Andrea Sottoriva, et al.
Contraception|February 14, 2012
Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trialLinda Hovanessian-Larsen, DeShawn Taylor, Debra Hawes, et al.
Science (New York, N.Y.)|November 6, 1970
Seismic data from man-made impacts on the moonG Latham, M Ewing, J Dorman, et al.
Archives of Pathology & Laboratory Medicine|April 16, 2016
Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation PracticeMichael F Press, Ivonne Villalobos, Angela Santiago, et al.
Science (New York, N.Y.)|June 2, 1972
Lunar crust: structure and compositionM N Toksöz, F Press, K Anderson, et al.
Gynecologic Oncology|February 1, 1989
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapyJ Rotmensch, R W Atcher, R Schlenker, et al.
Breast Cancer Research and Treatment|August 28, 2020
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patientsRamona Erber, Matthias Rübner, Simon Davenport, et al.
Human Pathology|June 1, 1996
Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinomaA Felix, A K El-Naggar, M F Press, et al.
Pageof 28

Showing results (111-120 of 273) with videos related to

Sort By:
Pageof 28
Science (New York, N.Y.)|July 18, 1986
Studies of the human c-myb gene and its product in human acute leukemiasD J Slamon, T C Boone, D C Murdock, et al.
Clinical Breast Cancer|September 3, 2005
Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumabRobert D Mass, Michael F Press, Steven Anderson, et al.
The Journal of Pathology|June 30, 2015
Many private mutations originate from the first few divisions of a human colorectal adenomaHaeyoun Kang, Matthew P Salomon, Andrea Sottoriva, et al.
Contraception|February 14, 2012
Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trialLinda Hovanessian-Larsen, DeShawn Taylor, Debra Hawes, et al.
Science (New York, N.Y.)|November 6, 1970
Seismic data from man-made impacts on the moonG Latham, M Ewing, J Dorman, et al.
Archives of Pathology & Laboratory Medicine|April 16, 2016
Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation PracticeMichael F Press, Ivonne Villalobos, Angela Santiago, et al.
Science (New York, N.Y.)|June 2, 1972
Lunar crust: structure and compositionM N Toksöz, F Press, K Anderson, et al.
Gynecologic Oncology|February 1, 1989
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapyJ Rotmensch, R W Atcher, R Schlenker, et al.
Breast Cancer Research and Treatment|August 28, 2020
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patientsRamona Erber, Matthias Rübner, Simon Davenport, et al.
Human Pathology|June 1, 1996
Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinomaA Felix, A K El-Naggar, M F Press, et al.
Pageof 28